Parkman Healthcare Partners »

Abivax SA F shares owned by Parkman Healthcare Partners

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Parkman Healthcare Partners from 13F filings

Historical chart of Parkman Healthcare Partners investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Parkman Healthcare Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Parkman Healthcare Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.7M 55k 84.90

More positions owned by Parkman Healthcare Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation (BSX)
Alnylam Pharmaceuticals (ALNY)
Insulet Corporation (PODD)
CVS Caremark Corporation (CVS)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Miragen Therapeutics (VRDN)
Zimmer Holdings (ZBH)
Stryker Corporation (SYK)
Qiagen Nv Com Shs (QGEN)
McKesson Corporation (MCK)
Danaher Corporation (DHR)
Kalvista Pharmaceuticals (KALV)
Uniqure Nv SHS (QURE)
Neurocrine Biosciences (NBIX)

View all positions for Parkman Healthcare Partners

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Cormorant Asset Management
Paradigm Biocapital Advisors
Caligan Partners
FMR
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Vestal Point Capital
Adage Capital Partners GP
Baker Bros. Advisors
Farallon Capital Management

View all funds holding Abivax SA F